Starship Abort and Lock-Up Overhang Drag SpaceX Stock Below IPO Price

SpaceX shares fall 44% from record high as Starship failure and looming insider share sales trigger sell-off, with short interest surging to 29% of free float.

SpaceX shares closed Friday well below their initial public offering price of $135, as a failed Starship test flight and the imminent expiry of insider share restrictions conspired to knock the stock from its post-IPO pedestal. The double blow has erased most of the gains from the company's historic June debut and left investors bracing for further turbulence.

The stock ended European trading at €108.40 (roughly $124), down 5.4% on the day and 14.8% lower over the prior seven sessions. That places it just 0.99% above a 52-week low of €107.34 set on July 17 — a level the shares have already brushed once. The 14-day relative strength index sits at 34.6, hovering in oversold territory, while the annualized volatility over the past 30 days has reached a staggering 93.2%, reflecting the extreme uncertainty surrounding the freshly listed company.

The immediate trigger for the sell-off was the abort of Starship Flight 13 on July 16. With four of the 33 Raptor engines failing to ignite, SpaceX shut down the countdown seconds before liftoff. The mission — which was slated to deploy 20 Starlink V3 satellites, test an in-flight engine restart, and splash down in the Indian Ocean — has been rescheduled for July 20 at 6:45 p.m. Eastern time. The company said it would replace two of the affected engines before the next attempt.

In a cruel twist of timing, a separate Falcon 9 mission on the same day successfully placed 21 satellites into orbit for the Space Development Agency, making its fourth flight and sticking a flawless landing. That routine win garnered scant attention amid the Starship drama.

Lock-Up Countdown Adds to the Glut

Compounding the operational setback is a structural overhang that threatens to flood the market with new shares. According to filings with the U.S. Securities and Exchange Commission, up to 1.37 billion insider and early-investor shares will become eligible for trading once lock-up periods expire shortly after the company's first quarterly earnings report as a public entity, expected on August 6. The initial tranche — 911.5 million shares with a paper value of around $123 billion — could begin hitting the market as early as the second trading day after the earnings release.

The current free float represents only about 4% of total shares outstanding, meaning a wave of insider selling would dramatically expand supply. Market watchers expect significant downward pressure if large holders decide to cash out, especially after a steep decline from the stock's record high of $225.64 reached on June 16 — a level from which the shares have now retreated 44%.

Short Sellers Pile On, Pentagon Talks Offer Faint Hope

The extended slide has drawn speculators betting on further losses. The short interest as a percentage of free float has surged from roughly 5–7% three weeks ago to 29%, representing about 185 million shares and a notional short position of roughly $25 billion. According to data from Ortex, short sellers are sitting on paper profits of approximately $8.7 billion.

Options activity tells a more nuanced story. CNBC reported that $350 million in premiums changed hands on Friday alone, with $290 million of that concentrated in puts. Yet nine of the ten largest single trades were bullish bets, suggesting that some large players are positioning for a rebound.

A potential bright spot emerged from reports that SpaceX is in talks with the Pentagon about a multibillion-dollar contract to supply data-center capacity for artificial intelligence applications, including work for the NSA. The Wall Street Journal said the company is offering to undercut cloud rival CoreWeave. The news briefly lifted the stock but couldn't offset the broader selling pressure.

Analyst Views Diverge Wildly

The fair-value debate among analysts is unusually wide. Raymond James sees a target of $800, while CFRA puts it at just $115. The consensus from roughly 27 to 37 analysts falls between $234 and $244.50 — well above current levels. Morningstar, however, pegs fair value at a mere $62. Piper Sandler initiated coverage with a neutral rating, and Cathie Wood bought roughly 122,800 shares worth about $16.6 million, according to Benzinga.

The company itself reported a net loss of $4.9 billion for 2025 and a loss of $4.28 billion in the first quarter of 2026. With the second Starship launch attempt set for July 20, the earnings report on August 6, and the lock-up expiry immediately afterward, the coming weeks will determine whether the stock can find a floor — or whether the post-IPO decline has further to run.